iCAD, Inc. (NASDAQ:ICAD) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET

Company Participants

Tony Takazawa - Director, Investor Relations

Stacey Stevens - President and Chief Executive Officer

Steve Sarno - Interim Chief Financial Officer

Conference Call Participants

Per Ostlund - Craig Hallum Capital Group

Sam Eiber - BTIG

Charlie Montang - Lake Street Capital

Francois Brisebois - Oppenheimer

Yale Jen - Laidlaw and Company

Operator

Good afternoon, ladies and gentlemen. And welcome to the iCAD, Inc. Second Quarter 2022 Earnings Call. [Operator instructions] It is now my pleasure to turn the floor over to your host, Tony Takazawa, Director of Investor Relations. Sir, the floor is yours.

Tony Takazawa

Thank you, Matthew. Good afternoon, everyone. Thank you for joining us today for iCAD's second quarter 2022 earnings conference call. On the call today, we have Stacey Stevens, our President and Chief Executive Officer; and Steve Sarno, our Interim Chief Financial Officer.

Before turning the call over to Stacey, I would like to remind everyone that we will be making forward-looking statements on the call today. These forward-looking statements are based on iCAD's, current expectations, and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these expectations. For our list of factors that could cause actual results to differ, please see today's press release and our filings with the U.S. Securities and Exchange Commission. iCAD undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this conference call. I would also note that management may refer to certain non-GAAP financial measures.

Management believes that these measures provide meaningful information for investors and reflect the way they view the operating performance of the company. You can find a reconciliation of our GAAP to non-GAAP measures at the end of the earnings release.

With that, I'll turn the call over to Stacey. Stacey?

Stacey Stevens

Thank you, Tony. And good afternoon, everyone. I will begin with some high level comments on the market environment and how this affects our current and potential customers. I will then discuss our second quarter results and provide further granularity around the key areas of focus for the company for the remainder of 2022. The market environment we have seen over the last quarter is consistent with what many companies across the healthcare industry have been experiencing and reporting. While access to customers has improved customer challenges with respect to capital budgets, critical staffing shortages and supply chains remain. There are also a range of other economic concerns such as rising inflation, the threat of recession and overall uncertainty that are continuing to affect current and future customers.